Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine dose effect on ropivacaine EC50 for caudal block in hemorrhoid surgery
ChiCTR1800015409Phase 4Recruiting
- Sponsor
- Chongqing Traditional Chinese Medicine Hospital
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and ropivacaine in hemorrhoid (5 arms), sponsored by Chongqing Traditional Chinese Medicine Hospital. Primary endpoint: Concentration of ropivacaine. Started Apr 2018; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR1800015409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015409.